[1]
Valera, P. et al. 2020. Angiotensin converting enzyme inhibitors, angiotensin receptor blockers, mineralocorticoid receptor antagonists and SARS-CoV-2 infection. SA Heart Journal. 17, 3 (Nov. 2020), 352–361. DOI:https://doi.org/10.24170/17-3-4383.